Results of a randomized, double-blind, vehicle-controlled efficacy trial of pimecrolimus cream 1% for the treatment of moderate to severe facial seborrheic dermatitis.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples